Results 11 to 20 of about 189,680 (382)

Ventilator-associated pneumonia [PDF]

open access: yesIntensive Care Medicine, 2022
Ventilator Associated Pneumonia (VAP) is the instance in which a patient acquires pneumonia more than forty-eight hours after intubation with mechanical ventilation.
Otavio T. Ranzani   +2 more
openaire   +4 more sources

Ventilator associated pneumonia [PDF]

open access: yesBMJ, 2006
Abstract Hospital acquired or nosocomial infections continue to be an important cause of morbidity and mortality. The critically ill patient is at particular risk of developing intensive care unit acquired infection, with the lungs being especially vulnerable.
Jason R. Leong, David T. Huang
openaire   +8 more sources

Ventilator-associated Pneumonia: A Narrative Review [PDF]

open access: yesAl-Anbar Medical Journal, 2022
The difficulty of early diagnosis, the proper anti-microbial chosen, and the relatively high morbidity and mortality; make us collect the related subjects to deal with the most critical complication (ventilator-associated pneumonia) showing the major ...
Hayder Alkayssi
doaj   +1 more source

Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update

open access: yesInfection control and hospital epidemiology, 2022
The purpose of this document is to highlight practical recommendations to assist acute care hospitals to prioritize and implement strategies to prevent ventilator-associated pneumonia (VAP), ventilator-associated events (VAE), and non-ventilator hospital-
M. Klompas   +12 more
semanticscholar   +1 more source

Ventilator-Associated Pneumonia [PDF]

open access: yesArchives of Internal Medicine, 2000
Ventilator-associated pneumonia is a common complication in intensive care units, occurring in 9% to 24% of patients intubated for longer than 48 hours. Because of this large disease burden and the resultant attributable morbidity and mortality, there is great interest in accurately diagnosing, treating, and preventing this complication.
Richard S Morehead, Simmy Jerry Pinto
openaire   +5 more sources

Ventilator-associated pneumonia in critically ill patients with COVID-19

open access: yesCritical Care, 2021
Pandemic COVID-19 caused by the coronavirus SARS-CoV-2 has a high incidence of patients with severe acute respiratory syndrome (SARS). Many of these patients require admission to an intensive care unit (ICU) for invasive ventilation and are at ...
Mailis Maes   +21 more
semanticscholar   +1 more source

New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia.

open access: yesSeminars in Respiratory and Critical Care Medicine, 2022
Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) represent one of the most common hospital-acquired infections, carrying a significant morbidity and risk of mortality. Increasing antibiotic resistance among the common bacterial
M. Bassetti   +4 more
semanticscholar   +1 more source

VENTILATOR ASSOCIATED PNEUMONIA IN TRAUMA PATIENTS; ASSOCIATED RISK FACTORS, MICROBIAL ETIOLOGY AND OUTCOME

open access: yesPakistan Armed Forces Medical Journal, 2021
Objective: To assess the incidence, risk factors and outcome of ventilator associated pneumonia in trauma patients. Study Design: Prospective observational study.
Sohaima Manzoor   +5 more
doaj   +1 more source

Effect of Gram Stain–Guided Initial Antibiotic Therapy on Clinical Response in Patients With Ventilator-Associated Pneumonia

open access: yesJAMA Network Open, 2022
This randomized clinical trial compares the clinical response to Gram stain–guided vs guideline-based antibiotic therapy in patients with ventilator-associated pneumonia.
J. Yoshimura   +11 more
semanticscholar   +1 more source

Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2021
Importance Growing interest in microbial dysbiosis during critical illness has raised questions about the therapeutic potential of microbiome modification with probiotics.
J. Johnstone   +499 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy